{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:01:27Z","timestamp":1790715687108,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":70,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201971"],"award-info":[{"award-number":["82201971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ22H100004"],"award-info":[{"award-number":["LQ22H100004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100621","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T23:07:32Z","timestamp":1743030452000},"page":"100621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk factors and predictive model for pulmonary arterial hypertension in adult idiopathic-inflammatory-myopathy patients: A cross-sectional study"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-3906","authenticated-orcid":false,"given":"Junyu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3436-9097","authenticated-orcid":false,"given":"Xiaoqun","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-6603","authenticated-orcid":false,"given":"Liyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9302-9774","authenticated-orcid":false,"given":"Xiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8801-1817","authenticated-orcid":false,"given":"Ye","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-4143","authenticated-orcid":false,"given":"Lanlan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8134-7449","authenticated-orcid":false,"given":"Yini","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7496-4885","authenticated-orcid":false,"given":"Hanyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-049X","authenticated-orcid":false,"given":"Heng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-0723","authenticated-orcid":false,"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinsp.2025.100621_bib0001","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2213-2600(24)00072-9","article-title":"TORREY study investigators. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomized, double-blind, placebo-controlled phase 2 trial","volume":"12","author":"Frantz","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"10366","key":"10.1016\/j.clinsp.2025.100621_bib0002","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0140-6736(22)01601-4","volume":"400","author":"Weatherald","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100621_bib0003","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.chest.2022.12.045","article-title":"Derivation of a risk score (REVEAL-ECHO) based on echocardiographic parameters of patients with pulmonary arterial hypertension","volume":"163","author":"El-Kersh","year":"2023","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.clinsp.2025.100621_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077122","article-title":"Analysis of cardiovascular risk factors for the viability of cornea donors: a case-control study","volume":"13","author":"Montero-Salinas","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100621_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.recesp.2016.01.002","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"69","author":"Gali\u00e8","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100621_bib0006","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10067-022-06446-y","article-title":"Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment","volume":"42","author":"Cansu","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100621_bib0007","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.42434","article-title":"Identification of novel associations and localization of signals in idiopathic inflammatory myopathies using genome-wide imputation","volume":"75","author":"Rothwell","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100621_bib0008","first-page":"359","article-title":"Current concepts and advances in dermatomyositis: a dermatological perspective","volume":"41","author":"Lim","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.clinsp.2025.100621_bib0009","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","article-title":"The lungs were on fire: a pilot study of (18)F-FDG PET\/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinsp.2025.100621_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1029057","article-title":"Pregnant outcomes of critically ill pregnant patients with pulmonary hypertension: a multicenter retrospective study","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.clinsp.2025.100621_bib0012","article-title":"Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: a 3-year survivorship analysis","volume":"9","author":"Lin","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100621_bib0013","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1093\/rheumatology\/keaa872","article-title":"Ventricular arrhythmia predicts poor outcome in polymyositis\/dermatomyositis with myocardial involvement","volume":"60","author":"Huang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100621_bib0014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.55563\/clinexprheumatol\/t7942l","article-title":"Clinical heterogeneities and prognoses of patients with myositis specific antibody negative dermatomyositis: a retrospective study in China","volume":"40","author":"Li","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100621_bib0015","doi-asserted-by":"crossref","first-page":"e13453","DOI":"10.1111\/eci.13453","article-title":"Pulmonary hypertension in connective tissue diseases, new evidence and challenges","volume":"51","author":"Vonk","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"16","key":"10.1016\/j.clinsp.2025.100621_bib0016","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMe2300324","article-title":"Continued progress in therapy for pulmonary arterial hypertension","volume":"388","author":"Taichman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinsp.2025.100621_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.940894","article-title":"Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension","volume":"9","author":"Duo","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100621_bib0018","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/HYPERTENSIONAHA.121.17868","article-title":"Caspase-4\/11-mediated pulmonary artery endothelial cell pyroptosis contributes to pulmonary arterial hypertension","volume":"79","author":"Wu","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100621_bib0019","doi-asserted-by":"crossref","first-page":"L472","DOI":"10.1152\/ajplung.00405.2019","article-title":"GLI1-mediated pulmonary artery smooth muscle cell pyroptosis contributes to hypoxia-induced pulmonary hypertension","volume":"318","author":"He","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clinsp.2025.100621_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cyto.2018.12.023","article-title":"Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis","volume":"116","author":"Andr\u00e9s Cerezo","year":"2019","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100621_bib0021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.55563\/clinexprheumatol\/yps7ai","article-title":"Infection is not rare in patients with idiopathic inflammatory myopathies","volume":"40","author":"Ge","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinsp.2025.100621_bib0022","article-title":"Cytokine expression of lung bacterial infection in newly diagnosed adult hematological malignancies","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0023","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12879-020-05270-6","article-title":"Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children","volume":"20","author":"Ling","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.clinsp.2025.100621_bib0024","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10495-022-01797-y","article-title":"Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension","volume":"28","author":"Li","year":"2023","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2010.03286.x","article-title":"Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach","volume":"17","author":"Cicalini","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100621_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2478\/jtim-2022-0054","article-title":"Characteristics of the severe acute Respiratory syndrome coronavirus 2 omicron BA.2 subvariant in Jilin, China from March to May 2022","volume":"10","author":"Liu","year":"2022","journal-title":"J Transl Int Med"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1756-185X.13001","article-title":"Pulmonary hypertension in connective tissue diseases: an update","volume":"20","author":"Aithala","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-020-02218-8","article-title":"Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension","volume":"22","author":"Di Benedetto","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100621_bib0029","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/1346-8138.13252","article-title":"Serum levels of interleukin-18-binding protein isoform a: clinical association with inflammation and pulmonary hypertension in systemic sclerosis","volume":"43","author":"Nakamura","year":"2016","journal-title":"J Dermatol"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100621_bib0030","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/art.40534","article-title":"CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosis","volume":"70","author":"Hoffmann-Vold","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-022-02734-9","article-title":"Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension","volume":"24","author":"Kolstad","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100621_bib0032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.55563\/clinexprheumatol\/1sx5yk","article-title":"Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis","volume":"40","author":"Eviatar","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100621_bib0033","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000510048","article-title":"In situ evidence of collagen V and interleukin-6\/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension","volume":"87","author":"Batah","year":"2020","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100621_bib0034","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/678511","article-title":"Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution","volume":"4","author":"Park","year":"2014","journal-title":"Pulm Circ"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100621_bib0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/thoraxjnl-2018-211846","article-title":"Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of beta-catenin","volume":"74","author":"Wang","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.clinsp.2025.100621_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1019972","article-title":"Anti-SRP immune-mediated necrotizing myopathy: a critical review of current concepts","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100621_bib0037","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and Respiratory complications of necrotizing autoimmune myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinsp.2025.100621_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113936","article-title":"The pathogenesis of anti-signal recognition particle necrotizing myopathy: a review","volume":"156","author":"Qiu","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinsp.2025.100621_bib0039","article-title":"Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease","volume":"32","author":"Baah","year":"2021","journal-title":"Respir Med Case Rep"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100621_bib0040","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/kez517","article-title":"Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis","volume":"59","author":"Miyagawa","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322500047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322500047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:03:26Z","timestamp":1790712206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322500047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S180759322500047X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100621","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and predictive model for pulmonary arterial hypertension in adult idiopathic-inflammatory-myopathy patients: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100621"}}